Search research articles
Contact Us
Filters
Showing results (101-110 of 331) with videos related to
Page
of 34
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 10, 2018
Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study
Gerald M Devins, Kenneth Mah, Hans A Messner, et al.
Biochemistry
|
May 26, 1981
Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase
M R Emmerling, C D Johnson, D F Mosher, et al.
European Journal of Haematology
|
July 1, 1996
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study
J H Lipton, H A Messner, J E Curtis, et al.
Leukemia & Lymphoma
|
August 9, 2023
High sensitivity c-reactive protein and circulating biomarkers of endothelial dysfunction in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Nazanin Aghel, Dakota Gustafson, Diego Delgado, et al.
Bone Marrow Transplantation
|
May 1, 1997
Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants
F Z Al-Fiar, R Colwill, J H Lipton, et al.
American Journal of Hematology
|
March 13, 2014
BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase
Dennis Dong Hwan Kim, Nada Hamad, Hong Gi Lee, et al.
The New England Journal of Medicine
|
October 19, 1989
The effect of cyclosporine on the use of hospital resources for kidney transplantation
J Showstack, P Katz, W Amend, et al.
Hematology (Amsterdam, Netherlands)
|
May 15, 2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias
V Gupta, S Kamel-Reid, M D Minden, et al.
Surgery
|
December 1, 1978
Optimal myocardial protection
R D Weisel, B S Goldman, I H Lipton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation
T L Kiss, M Abdolell, N Jamal, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 331) with videos related to
Sort By:
Page
of 34
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 10, 2018
Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study
Gerald M Devins, Kenneth Mah, Hans A Messner, et al.
Biochemistry
|
May 26, 1981
Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase
M R Emmerling, C D Johnson, D F Mosher, et al.
European Journal of Haematology
|
July 1, 1996
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study
J H Lipton, H A Messner, J E Curtis, et al.
Leukemia & Lymphoma
|
August 9, 2023
High sensitivity c-reactive protein and circulating biomarkers of endothelial dysfunction in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Nazanin Aghel, Dakota Gustafson, Diego Delgado, et al.
Bone Marrow Transplantation
|
May 1, 1997
Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants
F Z Al-Fiar, R Colwill, J H Lipton, et al.
American Journal of Hematology
|
March 13, 2014
BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase
Dennis Dong Hwan Kim, Nada Hamad, Hong Gi Lee, et al.
The New England Journal of Medicine
|
October 19, 1989
The effect of cyclosporine on the use of hospital resources for kidney transplantation
J Showstack, P Katz, W Amend, et al.
Hematology (Amsterdam, Netherlands)
|
May 15, 2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias
V Gupta, S Kamel-Reid, M D Minden, et al.
Surgery
|
December 1, 1978
Optimal myocardial protection
R D Weisel, B S Goldman, I H Lipton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation
T L Kiss, M Abdolell, N Jamal, et al.
Page
of 34